CD146 is a potential immunotarget for neuroblastoma-Reference-Cited by-同舟云学术

CD146 is a potential immunotarget for neuroblastoma

Published:2021-09-30 Issue:11 Volume:112 Page:4617-4626
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Obu Satoshi¹,Umeda Katsutsugu¹^ORCID,Ueno Hiroo¹^ORCID,Sonoda Mari²,Tasaka Keiji¹^ORCID,Ogata Hideto¹,Kouzuki Kagehiro¹,Nodomi Seishiro¹,Saida Satoshi¹^ORCID,Kato Itaru¹^ORCID,Hiramatsu Hidefumi¹^ORCID,Okamoto Tatsuya²^ORCID,Ogawa Eri²^ORCID,Okajima Hideaki²³^ORCID,Morita Ken⁴^ORCID,Kamikubo Yasuhiko⁴^ORCID,Kawaguchi Koji⁵^ORCID,Watanabe Kenichiro⁵^ORCID,Iwafuchi Hideto⁶^ORCID,Yagyu Shigeki⁷^ORCID,Iehara Tomoko⁷^ORCID,Hosoi Hajime⁷^ORCID,Nakahata Tatsutoshi⁸^ORCID,Adachi Souichi⁴^ORCID,Uemoto Shinji²^ORCID,Heike Toshio¹^ORCID,Takita Junko¹^ORCID

Affiliation:

1. Department of Pediatrics Graduate School of Medicine Kyoto University Kyoto Japan

2. Department of Pediatric Surgery Graduate School of Medicine Kyoto University Kyoto Japan

3. Department of Pediatric Surgery Kanazawa Medical University Ishikawa Japan

4. Department of Human Health Science Graduate School of Medicine Kyoto University Kyoto Japan

5. Department of Hematology and Oncology Shizuoka Children’s Hospital Shizuoka Japan

6. Department of Pathology Shizuoka Children’s Hospital Shizuoka Japan

7. Department of Pediatrics Graduate School of Medical Science Kyoto Prefectural University of Medicine Kyoto Japan

8. Drug Discovery Technology Development Office Center for iPS Cell Research and Application Kyoto University Kyoto Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15124

Reference49 articles.

1. Declining childhood and adolescent cancer mortality

2. Advances in Risk Classification and Treatment Strategies for Neuroblastoma

3. Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project

4. Survival and late effects in children with stage 4 neuroblastoma

5. Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/Akt Signaling Pathway;Frontiers in Bioscience-Landmark;2024-04-08

2. Identification of potential molecular targets for the treatment of cluster 1 human pheochromocytoma and paraganglioma via comprehensive proteomic characterization;Clinical Proteomics;2023-09-25

3. CD146‐targeted nuclear medicine imaging in cancer: State of the art;VIEW;2023-03

4. Targeted surface marker screening on neuronal structures in the human choroid;Experimental Eye Research;2023-02

5. Functional Diversity of Neuronal Cell Adhesion and Recognition Molecule L1CAM through Proteolytic Cleavage;Cells;2022-09-30